MedTrace Logo

Remote Temperature Monitoring of Patients At Risk for Developing Fever

NCT06752512 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-12-30

No results posted yet for this study

Summary

The purpose of this program is to evaluate remote temperature monitoring in cancer patients at risk of fever and infection due to chemotherapy treatment. The main questions it aims to answer are:

* does remote temperature monitoring reduce the number of days spent inpatient
* what out-of-pocket cost can a patient expect to incur for participating in remote temperature monitoring
* the number of billable CPT codes that will be generated by providing remote temperature monitoring

Researchers will compare compliant and non-compliant patients to assess if compliance with remote temperature monitoring is associated with a decrease in the number of days spent inpatient.

Patients will

* wear the thermometer for the duration of their participation in the study
* have their temperature monitored continuously
* receive alerts on their phone when their temperature exceeds a threshold for a sustained duration, configurable by their physician
* respond to texts or calls from remote monitors when an alert is triggered

Conditions

Interventions

DEVICE

Remote Patient Monitoring

24/7 remote patient monitoring with a wearable thermometer

Sponsors & Collaborators

  • Ellis Medicine

    collaborator OTHER

  • AION Biosystems

    lead INDUSTRY

Principal Investigators

  • Tallat Mahmood, M.D. · Ellis Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-09
Primary Completion
2025-01-31
Completion
2025-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06752512 on ClinicalTrials.gov